Navigation Links
Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
Date:5/1/2008

E-MEDS Act Would Require Electronic Prescribing in Medicare

WASHINGTON, May 1 /PRNewswire-USNewswire/ -- In a strong signal of support, a broad group of consumers, employers, unions, and medical professionals have signed a letter to Congressional leaders urging passage of legislation that would require electronic prescribing (e-prescribing) in Medicare, the Pharmaceutical Care Management Association announced today.

"This broad support for an e-prescribing requirement in Medicare underscores how important this issue is in the current Medicare debate," said PCMA President and CEO Mark Merritt. "E-prescribing saves lives and money, and is the first step toward broader health IT reform."

Supporters of the "Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007" include:

Consumer/Labor Groups

AARP

AFL-CIO

Consumers Union

National Consumers League

National Partnership for Women & Families

SEIU

Business/Public Purchasers

AT&T

Caterpillar Inc.

Cisco Systems

Corporate Health Care Coalition

Dell

The Dow Chemical Company

EDS

The ERISA Industry Committee

Ford Motor Company

General Motors Corporation

HR Policy Association

Information Technology Industry Council

National Business Group on Health

National Retail Federation

NCR Corporation

Oracle

Public Sector HealthCare Roundtable

Southeastern Michigan ePrescribing Initiative (SEMI)

Texas Instruments

UPS

Verizon Communications

Xerox Corporation

Prescription Drug Stakeholders

Pharmaceutical Care Management Association (PCMA)

Aetna

Barr Pharmaceuticals, Inc.

BlueCross BlueShield Association

CIGNA

CVS Caremark

Coalition for a Competitive Pharmaceutical Market

Express Scripts, Inc.

Generic Pharmaceutical Association

Medco Health Solutions, Inc.

Mylan Inc.

National Association of Chain Drug Stores

Teva Pharmaceuticals

United Health Group

WellPoint

Medical Professionals

American Medical Group Association

The bipartisan "Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007" would require e-prescribing in Medicare. The E-MEDS Act was introduced by Senate Finance Committee Members John Kerry (D-Mass.) and John Ensign (R-Nev.), and enjoys support from 12 additional co-sponsors, including Senators Debbie Stabenow (D-Mich.), John Sununu (R-NH), Joe Lieberman (I-Conn.), and Hillary Rodham Clinton (D-N.Y.). Companion legislation was introduced in the House by Representatives Allyson Schwartz (D-Penn.) and Jon Porter (R-Nev.), and currently has 29 total co-sponsors.

Copy of letter available at http://www.pcmanet.org

###

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
2. Quixtar Files Suit Against MonaVie To Protect Consumers, Halt Unfair Competition
3. Consumers, Health Care Purchasers Applaud Agreement On Physician Performance Reporting
4. Phyhealth Appoints Gerald H. Priceman as Medical Director
5. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
6. Excruciatingly Embarrassing Moment for The Medical Board of California: Complete Meltdown of the Friday, April 25th Quarterly Meeting: by T. L. Kittle
7. OPEN LETTER: Medical Journal Calls Upon Barack Obama to Set the Record Straight on AIDS Virus
8. Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference
9. Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center
10. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
11. BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: